Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Strum

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Annals of Internal Medicine|August 2, 2017
The Scientific Basis of Guideline Recommendations on Sugar IntakeStephen Strum
Annals of Internal Medicine|April 18, 2012
Inviting patients to read doctors' notesStephen Strum
Annals of Internal Medicine|April 2, 2019
Michael's TestimonialStephen Strum
The Journal of Urology|May 10, 2005
Long-term outcome for men with androgen independent prostate cancer treated with ketoconazole and hydrocortisoneMark Scholz, Robert Jennrich, Stephen Strum, et al.
Urology|October 2, 2007
Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticalsMark Scholz, Richard Lam, Stephen Strum, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Annals of Internal Medicine|August 2, 2017
The Scientific Basis of Guideline Recommendations on Sugar IntakeStephen Strum
Annals of Internal Medicine|April 18, 2012
Inviting patients to read doctors' notesStephen Strum
Annals of Internal Medicine|April 2, 2019
Michael's TestimonialStephen Strum
The Journal of Urology|May 10, 2005
Long-term outcome for men with androgen independent prostate cancer treated with ketoconazole and hydrocortisoneMark Scholz, Robert Jennrich, Stephen Strum, et al.
Urology|October 2, 2007
Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticalsMark Scholz, Richard Lam, Stephen Strum, et al.
Pageof 1